Prakt. lékáren. 2022; 18(3): 156-159 | DOI: 10.36290/lek.2022.032

Probiotics and their use in treatment of gastrointestinal disorders

Vít Navrátil
II. interní klinika - gastroenterologická a geriatrická, Fakultní nemocnice Olomouc

Probiotics are agents containing living microorganisms that could cause improvement of health condition of the recipient. Recently they are not only often advertised, but also studied regarding their effectiveness and safety. Probably the most-studied species are Lactobacillus, Bifidobacterium, Saccharomyces and strain Escherichia coli Nissle 1917. Their effect is complex and include immunomodulation, suppression of pathogen growth and improvement of barrier function of the gut epithelium. They are used in a whole range of diseases and conditions, especially in gastroenterological indications. Nevertheless, scientific data regarding their usage are often disputable, so it is important to always consider the correct indication to use them.

Keywords: probiotics, microorganisms, Lactobacillus, Bifidobacterium, Saccharomyces, Escherichia coli Nissle 1917, diarrhea.

Accepted: October 13, 2022; Published: October 27, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátil V. Probiotics and their use in treatment of gastrointestinal disorders. Praktické lékárenství. 2022;18(3):156-159. doi: 10.36290/lek.2022.032.
Download citation

References

  1. Lilly DM, Stillwell RH. Probiotics: Growth­‑Promoting Factors Produced by Microorganisms. Science. 1965;147(3659):747-748. Go to original source... Go to PubMed...
  2. Rada V. Využití probiotik, prebiotik a synbiotik. Med. Praxi. 2011;8(1):10-15.
  3. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989; 66(5):365-378. Go to original source... Go to PubMed...
  4. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. Go to original source... Go to PubMed...
  5. Ozen M, Dinleyici EC. The history of probiotics: the untold story. Benef Microbes. 2015;6(2):159-165. Go to original source... Go to PubMed...
  6. Lukáš M. Mutaflor® - Escherichia coli (Nissle 1917), sérotyp O6:K5:H1 - nejlépe prozkoumané probiotikum současnosti. Gastroent Hepatol. 2016;70(3):281-282. Go to original source...
  7. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17(2): 259-275. Go to original source... Go to PubMed...
  8. Frühauf P. Střevní mikrobiota a možnosti ovlivnění. Pediatr. praxi. 2017;18(4):239-242
  9. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716-729. Go to original source... Go to PubMed...
  10. Kohout P. Probiotika v rukou praktického lékaře. Med. Pro Praxi 2009;6(3):135-139.
  11. Tsai CC, Hsih HY, Chiu HH, et al. Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. Int J Food Microbiol. 2005;102(2):185-194. Go to original source... Go to PubMed...
  12. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G807-G819. Go to original source... Go to PubMed...
  13. Kristensen NB, Bryrup T, Allin KH, et al. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 2016;8,52. Go to original source... Go to PubMed...
  14. Williams NT. Probiotics. Am J Health Syst Pharm. 2010; 67(6):449-458. Go to original source... Go to PubMed...
  15. Yeh A, Morowitz MJ. Probiotics and fecal microbiota transplantation in surgical disorders. Semin. Colon Rectal Surg. 2018;29:37-43. Go to original source...
  16. Lata J, Juránková J. Střevní mikroflóra, slizniční bariéra a probiotika u některých interních chorob. Interní Med. 2011; 13(2):63-69.
  17. Bortlík M. Probiotika v gastroenterologii. Remedia. 2009; 19(1):47-51.
  18. Bogdanová K, Doubravská L, Vágnerová I, et al. Clostridioides difficile and Vancomycin­‑Resistant Enterococci in COVID-19 Patients with Severe Pneumonia. Life (Basel). 2021;11(11):1127. Go to original source... Go to PubMed...
  19. Lukáš M. Prebiotika, probiotika a střevní mikroflora. Interní Med. 2015;17(1):14-17.
  20. Nevoral J. Probiotika v pediatrii, co je prokázané a co dosud není. Pediatr. praxi 2015;16(2):108-112.
  21. Wilkins T, Sequoia J. Probiotics for Gastrointestinal Conditions: A Summary of the Evidence. Am Fam Physician. 2017;96(3):170-178. Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.